Podcasts

AHA-ACC experts defend new risk formula in presser


 

The recent prevention guidelines issued by the American Heart Association and the American College of Cardiology became the center of some controversy during AHA's annual meeting, when word got out that a commentary by two researchers, saying that the guidelines' risk calculation formula is flawed, would be published in The Lancet*.

To respond to the comments by Dr. Paul M. Ridker and Ms. Nancy R. Cook, both from Brigham and Women’s Hospital in Boston, AHA and ACC officials held a press conference on Monday, November 18. This is the full audio of the statements made by the experts involved in the drafting of the guidelines.

*Updated:The Lancet article was published on Nov. 19.

@NaseemSMiller

Recommended Reading

Combined angiotensin inhibition raises hyperkalemia, acute kidney injury risks
MDedge Internal Medicine
Improved outcomes with CoreValve in extreme-risk patients
MDedge Internal Medicine
Hydrocodone rescheduling: Intended and unintended consequences
MDedge Internal Medicine
ACC-AHA cardiovascular prevention guidelines drop cholesterol treatment goals
MDedge Internal Medicine
Mindful meditation shows promise for BP lowering in CKD
MDedge Internal Medicine
Cardiovascular risk factors common with breast cancer
MDedge Internal Medicine
First U.S. TAVR experience fares well post-market
MDedge Internal Medicine
Intervention boosts post-acute coronary syndrome medication adherence, but not outcomes
MDedge Internal Medicine
CORAL: No added benefit with renal stenting vs. medication alone
MDedge Internal Medicine
Varespladib raises MI risk after recent acute coronary syndrome
MDedge Internal Medicine